Ikarian Capital, LLC Ovid Therapeutics Inc. Call Options Transaction History
Ikarian Capital, LLC
- $754 Million
- Q1 2024
Call Options
2 transactions
Others Institutions Holding OVID
# of Institutions
82Shares Held
43.1MCall Options Held
5.9KPut Options Held
300-
Eco R1 Capital, LLC San Francisco, CA6.12MShares$6.24 Million0.53% of portfolio
-
Rubric Capital Management LP New York, NY5.32MShares$5.42 Million0.55% of portfolio
-
Black Rock Inc. New York, NY4.2MShares$4.28 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$3.93 Million0.35% of portfolio
-
Madison Avenue Partners, LP New York, NY3.65MShares$3.72 Million2.22% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $71.8M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...